Form 8-K - Current report:
SEC Accession No. 0001104659-21-100062
Filing Date
2021-08-04
Accepted
2021-08-04 16:05:51
Documents
12
Period of Report
2021-08-03
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2124062d1_8k.htm   iXBRL 8-K 48117
  Complete submission text file 0001104659-21-100062.txt   222211

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA avdl-20210803.xsd EX-101.SCH 3182
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20210803_lab.xml EX-101.LAB 34593
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avdl-20210803_pre.xml EX-101.PRE 22708
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2124062d1_8k_htm.xml XML 3473
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 211143983
SIC: 2834 Pharmaceutical Preparations